Woojin Yoon

Woojin Yoon

Auto-generated profile, based on publicly available information

Woojin Yoon

Department of Chemistry and Energy Systems Research, Ajou University, Suwon 16499, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2021 in Catalysts
Verified
Journal Article
Open access
PDF file
YCYeon-Joo Cheong
Yeon-Joo Cheong
KSKihyuk Sung
Kihyuk Sung
JKJin-A Kim
Jin-A Kim
Yu Kwon KimYu Kwon Kim
Yu Kwon Kim
WYWoojin Yoon
Woojin Yoon
Hye-Young JangHye-Young Jang
Hye-Young Jang
Iridium(NHC)-catalyzed transfer hydrogenation (TH) of CO2 and inorganic carbonates with glycerol were conducted, demonstrating excellent turnover numbers (TONs) and turnover frequencies (TOFs) for the formation of formate and lactate. Regardless of carbon sources, excellent TOFs of formate were observed (CO2: 10,000 h−1 and K2CO3: 10,150 h−1). Iridium catalysts modified with the triscarbene ligand showed excellent catalytic activity at 200 °C and are a suitable choice for this transformation which requires a high temperature for high TONs of formate. On the basis of the control experiments, the transfer hydrogenation mechanism of CO2 was proposed.

14 July 2017 in Molecules
Verified
Journal Article
Open access
PDF file
Ji-Hun AnJi-Hun An
Ji-Hun An
AKAlice Nguvoko Kiyonga
Alice Nguvoko Kiyonga
WYWoojin Yoon
Woojin Yoon
HRHyung Chul Ryu
Hyung Chul Ryu
JKJae-Sun Kim
Jae-Sun Kim
KJKiwon Jung
Kiwon Jung
Tenofovir disoproxil (TD), an anti-virus drug, is currently marketed under its most stable form, Form-I of Tenofovir disoproxil fumarate (TDF). However, studies regarding the properties of TD free base crystal as a promising drug as well as its crystal structure have not yet been reported. This assumption was made because TD free base is not directly produced in a solid form during the manufacturing process. TD free base is first obtained in an oil form, and is then synthesized into TDF crystal. In this regard, the present study was conducted to investigate both the potentiality of TD free base to be an active pharmaceutical ingredient (API) and its crystal structure. Here, TD free base solid was produced by means of drowning-out crystallization. Next, single crystal X-ray diffraction (SXD) was employed to determine the crystal structure. Powder X-ray diffraction (PXRD) and a differential scanning calorimetry (DSC) analysis were performed to evaluate the crystal’s properties. Furthermore, experiments were carried out at 15%, 35%, 55%, 75%, and 95% relative humidity (RH) for 12 h using a hygroscopic tester to determine and to compare the hygroscopicity and stability of TD free base with TDF crystal. Additionally, experiments were conducted under accelerated (40 °C, RH 75%) and stress storage (60 °C, RH 75%) conditions for 30 days to investigate the changes in purity and the formation of dimer. In this work, we report that TD free base possesses lower hygroscopicity, and thus does not generate dimer impurity from hydrolysis. Primarily, this is attributed to the fact that TD free base is not an easily ionized salt but comprises neutral hydrophobic molecules. According to the structural properties, the improved hygroscopic property of the TD free base crystal was due to the decrease of crystal polarity owing to the intermolecular H-bonds present in TD free base rings. In addition, the solubility investigation study carried out in aqueous solution and at gastrointestinal pH revealed a similarity in TDF and TD free base solubility under the mentioned conditions. Accordingly, we could confirm the potentiality of TD free base as an active pharmaceutical ingredient.

23 September 2017 in Crystals
Verified
Journal Article
Open access
PDF file
Ji-Hun AnJi-Hun An
Ji-Hun An
AKAlice Nguvoko Kiyonga
Alice Nguvoko Kiyonga
WYWoojin Yoon
Woojin Yoon
MPMinho Park
Minho Park
CLChangjin Lim
Changjin Lim
KJKiwon Jung
Kiwon Jung
The present work aims to investigate the applicability of ionic liquids (ILs) for natural ingredient crystallization. First, the medicinal plant, namely Angelica gigas Nakai, was extracted using methanol (MeOH) as a solvent. Afterwards, ILs 1-butyl-3-methylimidazolium tetrafluoroborate (BMImBF4), 1-butyl-3-methylimidazolium hexafluorophosphate (BMImPF6), 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide (BMImTFSI), 1-allyl-3-ethylim idazolium tetrafluoroborate (AEImBF4), and 1,3-diallyl imidazolium tetrafluoroborate (AAImBF4), in three ratios of 1:1, 1:2, and 1:3 (extraction solution/ILs (v/v)) were used as an anti-solvent to induce crystallization. Crystals were obtained within 8 h and were then identified to be pure crystals of sucrose through nuclear magnetic resonance (1H-NMR) analysis. Moreover, the single-crystal X-ray diffraction (SXD) analysis revealed all recovered crystals have an identical crystal structure and the morphology was monitored using a video microscope. With the application of BMImBF4 and BMImPF6, transformation of sucrose crystal morphology from an elongated hexagon shape to an elongated rectangular shape was observed with respect to the respective concentration increase. Here, all crystals precipitated from BMImBF4 and BMImPF6 were found to possess identical PXRD patterns. However, when BMImTFSI was employed, small rectangular crystals attached to the larger rectangular-shaped crystals due to secondary nucleation and shapeless amorphous forms were observed according to the alteration in the solution to ILs ratio. Accordingly, the ability of ILs as a relevant anti-solvent for the selective crystallization of a single compound from a natural product was assessed through the study. Furthermore, the applicability of ILs as crystal engineering solvents are expected to modify both the solid state and the crystal morphology of natural compounds, which can influence drug manufacturability, dissolution rate, and bioavailability.

1 March 2023 in Crystals
Verified
Journal Article
Open access
PDF file
JFJin Feng
Jin Feng
CLChangjin Lim
Changjin Lim
SNSihyun Nam
Sihyun Nam
WYWoojin Yoon
Woojin Yoon
HYHoseop Yun
Hoseop Yun
Ji-Hun AnJi-Hun An
Ji-Hun An
In this study, a dabigatran etexilate edisylate (DBE) was prepared by the reaction crystallization of dabigatran etexilate (DBG) and edisilic acid. According to single crystal X-ray diffraction (SXRD), it was revealed that two DGB were combined with one edisylate and associated with one water for DBE monohydrate. Additionally, the hot stage microscopy showed that the DBE monohydrate was transformed to DBE amorphous solid and then finally shifted to the DBE anhydrate in solid-state. Using powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and a hygroscopic test, it was confirmed that the phase transformation of DBE monohydrate to DBE anhydrate was irreversible. Additionally, any other crystal form of DBE anhydrate was not available because it was the most stable phase.